The domestic sleep medicine market currently faces a significant gap. Remetidine, as a high-quality product specifically designed to address sleep difficulties, possesses complete regulatory compliance qualifications, extensive clinical application scenarios, strong terminal sales capabilities, and no malicious competition from similar products. It offers diversified collaboration models tailored for major pharmaceutical manufacturers and pharmaceutical enterprises. Whether for established drug companies expanding into new product categories or transitioning pharmaceutical firms entering blue ocean markets, this approach enables low-risk entry and high-return profitability, rapidly establishing leadership in the sleep medicine niche.

▶Seek to expand high-margin product categories for pharmaceutical companies? 

▶Planning to enter the high-demand sleep medicine sector? 

▶Want to ride the traffic wave of the Chongming Sleep Challenge and rapidly launch blockbuster products? 

Limited slots are available for the first batch of strategic pharmaceutical partners, with priority given to securing regional exclusive cooperation rights to seize market opportunities!